Viewing StudyNCT03140176



Ignite Creation Date: 2024-05-06 @ 10:03 AM
Last Modification Date: 2024-10-26 @ 12:23 PM
Study NCT ID: NCT03140176
Status: TERMINATED
Last Update Posted: 2024-05-10
First Post: 2017-05-02

Brief Title: Real-world Clinical Patterns Of Care And Outcomes Among AfME mRCC Patients Receiving Sunitinib as First Line Therapy
Sponsor: Pfizer
Organization: Pfizer

Conditions & Keywords Data

Conditions:
Name
Metastatic Renal Cell Carcinoma
Keywords:
Name View
Africa Middle East View
Sunitinib View
Metastatic Renal Cell Carcinoma View